The Therapeutic Potential of Amphetamine-like Psychostimulants

Detalhes bibliográficos
Autor(a) principal: Pires, Bruno
Data de Publicação: 2023
Outros Autores: Rosendo, Luana M., Brinca, Ana Teresa, Simão, Ana Y., Barroso, Mário, Rosado, Tiago, Gallardo, Eugenia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.26/48616
https://doi.org/10.3390/life13112180
Resumo: This review delves into the therapeutic applications of amphetamine-type stimulants such as lisdexamphetamine dimesylate, mixed amphetamine salts, 3,4-methylenedioxymethamphetamine (MDMA), dextroamphetamine, and phentermine. These compounds have been investigated for their potential in treating a range of psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), drug dependence, post-traumatic stress disorder (PTSD), and obesity. Lisdexamphetamine dimesylate has shown promise in effectively treating ADHD symptoms in both children and adults. Additionally, it has been explored as a potential treatment for drug dependency and withdrawal, demonstrating encouraging results. Mixed amphetamine salts have also exhibited efficacy in reducing ADHD symptoms in adults. Future research should explore their potential use in treating bipolar disorder and cocaine dependence, considering the associated risks and benefits. MDMA-assisted psychotherapy has emerged as an innovative approach to treating PTSD, leading to sustained reductions in symptoms and even promoting post-traumatic growth. Furthermore, it has shown promise in managing anxiety related to life-threatening illnesses. Dextroamphetamine and phentermine have demonstrated efficacy in treating cocaine and opioid dependence, ADHD, and obesity. However, careful consideration and monitoring by medical professionals are essential due to the potential risks and benefits associated with them. In conclusion, amphetamine-type stimulants present a promising avenue for therapeutic interventions in various psychiatric conditions. Nevertheless, further research is necessary to comprehensively understand their mechanisms of action, dosage requirements, and long-term effects in different patient populations.
id RCAP_99b17b4972f6d685c71de74d55d8db89
oai_identifier_str oai:comum.rcaap.pt:10400.26/48616
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The Therapeutic Potential of Amphetamine-like PsychostimulantsAmphetaminesStimulantsTherapeuticThis review delves into the therapeutic applications of amphetamine-type stimulants such as lisdexamphetamine dimesylate, mixed amphetamine salts, 3,4-methylenedioxymethamphetamine (MDMA), dextroamphetamine, and phentermine. These compounds have been investigated for their potential in treating a range of psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), drug dependence, post-traumatic stress disorder (PTSD), and obesity. Lisdexamphetamine dimesylate has shown promise in effectively treating ADHD symptoms in both children and adults. Additionally, it has been explored as a potential treatment for drug dependency and withdrawal, demonstrating encouraging results. Mixed amphetamine salts have also exhibited efficacy in reducing ADHD symptoms in adults. Future research should explore their potential use in treating bipolar disorder and cocaine dependence, considering the associated risks and benefits. MDMA-assisted psychotherapy has emerged as an innovative approach to treating PTSD, leading to sustained reductions in symptoms and even promoting post-traumatic growth. Furthermore, it has shown promise in managing anxiety related to life-threatening illnesses. Dextroamphetamine and phentermine have demonstrated efficacy in treating cocaine and opioid dependence, ADHD, and obesity. However, careful consideration and monitoring by medical professionals are essential due to the potential risks and benefits associated with them. In conclusion, amphetamine-type stimulants present a promising avenue for therapeutic interventions in various psychiatric conditions. Nevertheless, further research is necessary to comprehensively understand their mechanisms of action, dosage requirements, and long-term effects in different patient populations.info:eu-repo/semantics/publishedVersion2023-12-29T14:39:13Z2023-12-292023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10400.26/48616http://hdl.handle.net/10400.26/48616https://doi.org/10.3390/life13112180engPires B, Rosendo LM, Brinca AT, Simão AY, Barroso M, Rosado T, Gallardo E. The Therapeutic Potential of Amphetamine-like Psychostimulants. Life. 2023; 13(11):2180http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessPires, BrunoRosendo, Luana M.Brinca, Ana TeresaSimão, Ana Y.Barroso, MárioRosado, TiagoGallardo, Eugeniareponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-03T04:22:40Zoai:comum.rcaap.pt:10400.26/48616Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:07:52.019554Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The Therapeutic Potential of Amphetamine-like Psychostimulants
title The Therapeutic Potential of Amphetamine-like Psychostimulants
spellingShingle The Therapeutic Potential of Amphetamine-like Psychostimulants
Pires, Bruno
Amphetamines
Stimulants
Therapeutic
title_short The Therapeutic Potential of Amphetamine-like Psychostimulants
title_full The Therapeutic Potential of Amphetamine-like Psychostimulants
title_fullStr The Therapeutic Potential of Amphetamine-like Psychostimulants
title_full_unstemmed The Therapeutic Potential of Amphetamine-like Psychostimulants
title_sort The Therapeutic Potential of Amphetamine-like Psychostimulants
author Pires, Bruno
author_facet Pires, Bruno
Rosendo, Luana M.
Brinca, Ana Teresa
Simão, Ana Y.
Barroso, Mário
Rosado, Tiago
Gallardo, Eugenia
author_role author
author2 Rosendo, Luana M.
Brinca, Ana Teresa
Simão, Ana Y.
Barroso, Mário
Rosado, Tiago
Gallardo, Eugenia
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pires, Bruno
Rosendo, Luana M.
Brinca, Ana Teresa
Simão, Ana Y.
Barroso, Mário
Rosado, Tiago
Gallardo, Eugenia
dc.subject.por.fl_str_mv Amphetamines
Stimulants
Therapeutic
topic Amphetamines
Stimulants
Therapeutic
description This review delves into the therapeutic applications of amphetamine-type stimulants such as lisdexamphetamine dimesylate, mixed amphetamine salts, 3,4-methylenedioxymethamphetamine (MDMA), dextroamphetamine, and phentermine. These compounds have been investigated for their potential in treating a range of psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), drug dependence, post-traumatic stress disorder (PTSD), and obesity. Lisdexamphetamine dimesylate has shown promise in effectively treating ADHD symptoms in both children and adults. Additionally, it has been explored as a potential treatment for drug dependency and withdrawal, demonstrating encouraging results. Mixed amphetamine salts have also exhibited efficacy in reducing ADHD symptoms in adults. Future research should explore their potential use in treating bipolar disorder and cocaine dependence, considering the associated risks and benefits. MDMA-assisted psychotherapy has emerged as an innovative approach to treating PTSD, leading to sustained reductions in symptoms and even promoting post-traumatic growth. Furthermore, it has shown promise in managing anxiety related to life-threatening illnesses. Dextroamphetamine and phentermine have demonstrated efficacy in treating cocaine and opioid dependence, ADHD, and obesity. However, careful consideration and monitoring by medical professionals are essential due to the potential risks and benefits associated with them. In conclusion, amphetamine-type stimulants present a promising avenue for therapeutic interventions in various psychiatric conditions. Nevertheless, further research is necessary to comprehensively understand their mechanisms of action, dosage requirements, and long-term effects in different patient populations.
publishDate 2023
dc.date.none.fl_str_mv 2023-12-29T14:39:13Z
2023-12-29
2023-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.26/48616
http://hdl.handle.net/10400.26/48616
https://doi.org/10.3390/life13112180
url http://hdl.handle.net/10400.26/48616
https://doi.org/10.3390/life13112180
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Pires B, Rosendo LM, Brinca AT, Simão AY, Barroso M, Rosado T, Gallardo E. The Therapeutic Potential of Amphetamine-like Psychostimulants. Life. 2023; 13(11):2180
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137167864233984